The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference185 articles.
1. Glucagon-like peptide 1 (GLP-1);Muller;Mol Metabol,2019
2. From the incretin concept and the discovery of GLP-1 to today's diabetes therapy;Holst;Front Endocrinol (Lausanne),2019
3. The glucagon-like peptides;Kieffer;Endocr Rev,1999
4. Mechanisms of action and therapeutic application of glucagon-like peptide-1;Drucker;Cell Metabol,2018
5. Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight;Baggio;J Clin Invest,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GLP-1R mediates idebenone-reduced blood glucose in mice;Biomedicine & Pharmacotherapy;2024-09
2. Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant;2024-08-07
3. Hepatic function of glucagon-like peptide-1 and its based diabetes drugs;Medical Review;2024-06-04
4. Comparative Analysis of the Anti-Inflammatory Effects of Liraglutide and Dulaglutide;International Heart Journal;2024-05-31
5. Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization;BMC Pulmonary Medicine;2024-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3